1. Home
  2. JXG vs AIMD Comparison

JXG vs AIMD Comparison

Compare JXG & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JXG
  • AIMD
  • Stock Information
  • Founded
  • JXG N/A
  • AIMD 1984
  • Country
  • JXG China
  • AIMD United States
  • Employees
  • JXG N/A
  • AIMD N/A
  • Industry
  • JXG
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • JXG
  • AIMD Health Care
  • Exchange
  • JXG Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • JXG 5.0M
  • AIMD 6.0M
  • IPO Year
  • JXG N/A
  • AIMD N/A
  • Fundamental
  • Price
  • JXG N/A
  • AIMD $0.47
  • Analyst Decision
  • JXG
  • AIMD
  • Analyst Count
  • JXG 0
  • AIMD 0
  • Target Price
  • JXG N/A
  • AIMD N/A
  • AVG Volume (30 Days)
  • JXG 434.6K
  • AIMD 131.2K
  • Earning Date
  • JXG 05-12-2025
  • AIMD 11-06-2024
  • Dividend Yield
  • JXG N/A
  • AIMD N/A
  • EPS Growth
  • JXG N/A
  • AIMD N/A
  • EPS
  • JXG 0.48
  • AIMD N/A
  • Revenue
  • JXG $31,840,588.00
  • AIMD $40,633.00
  • Revenue This Year
  • JXG N/A
  • AIMD N/A
  • Revenue Next Year
  • JXG N/A
  • AIMD N/A
  • P/E Ratio
  • JXG $1.71
  • AIMD N/A
  • Revenue Growth
  • JXG N/A
  • AIMD N/A
  • 52 Week Low
  • JXG $0.76
  • AIMD $0.40
  • 52 Week High
  • JXG $0.84
  • AIMD $4.29
  • Technical
  • Relative Strength Index (RSI)
  • JXG N/A
  • AIMD 49.07
  • Support Level
  • JXG N/A
  • AIMD $0.42
  • Resistance Level
  • JXG N/A
  • AIMD $0.53
  • Average True Range (ATR)
  • JXG 0.00
  • AIMD 0.04
  • MACD
  • JXG 0.00
  • AIMD 0.00
  • Stochastic Oscillator
  • JXG 0.00
  • AIMD 33.14

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: